
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai‐Ming Yu, Young Hee Choi, Mei‐Juan Tu
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 862-898
Open Access | Times Cited: 299
Ai‐Ming Yu, Young Hee Choi, Mei‐Juan Tu
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 862-898
Open Access | Times Cited: 299
Showing 1-25 of 299 citing articles:
Molecular photoswitches in aqueous environments
Jana Volarić, Wiktor Szymański, Nadja A. Simeth, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 22, pp. 12377-12449
Open Access | Times Cited: 275
Jana Volarić, Wiktor Szymański, Nadja A. Simeth, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 22, pp. 12377-12449
Open Access | Times Cited: 275
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Suzan M. Hammond, Annemieke Aartsma‐Rus, Sandra Alves, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 4
Open Access | Times Cited: 253
Suzan M. Hammond, Annemieke Aartsma‐Rus, Sandra Alves, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 4
Open Access | Times Cited: 253
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Gavin M. Traber, Ai‐Ming Yu
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 133-154
Open Access | Times Cited: 167
Gavin M. Traber, Ai‐Ming Yu
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 133-154
Open Access | Times Cited: 167
Engineering synthetic RNA devices for cell control
Peter B. Dykstra, Matias Kaplan, Christina D. Smolke
Nature Reviews Genetics (2022) Vol. 23, Iss. 4, pp. 215-228
Open Access | Times Cited: 78
Peter B. Dykstra, Matias Kaplan, Christina D. Smolke
Nature Reviews Genetics (2022) Vol. 23, Iss. 4, pp. 215-228
Open Access | Times Cited: 78
DrugMAP: molecular atlas and pharma-information of all drugs
Fengcheng Li, Jiayi Yin, Mingkun Lu, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1288-D1299
Open Access | Times Cited: 74
Fengcheng Li, Jiayi Yin, Mingkun Lu, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1288-D1299
Open Access | Times Cited: 74
RNA Therapeutics for the Cardiovascular System
Victor J. Dzau, Conrad P. Hodgkinson
Circulation (2024) Vol. 149, Iss. 9, pp. 707-716
Closed Access | Times Cited: 17
Victor J. Dzau, Conrad P. Hodgkinson
Circulation (2024) Vol. 149, Iss. 9, pp. 707-716
Closed Access | Times Cited: 17
MicroRNA as an Important Target for Anticancer Drug Development
Zhiwen Fu, Liu Wang, Shijun Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 94
Zhiwen Fu, Liu Wang, Shijun Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 94
VARIDT 2.0: structural variability of drug transporter
Tingting Fu, Fengcheng Li, Yang Zhang, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1417-D1431
Open Access | Times Cited: 78
Tingting Fu, Fengcheng Li, Yang Zhang, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1417-D1431
Open Access | Times Cited: 78
RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Κhan, Jawed A. Siddiqui, Imayavaramban Lakshmanan, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Parvez Κhan, Jawed A. Siddiqui, Imayavaramban Lakshmanan, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 77
A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation
Zhenxing Liang, Huashan Liu, Li Xiong, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 65
Zhenxing Liang, Huashan Liu, Li Xiong, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 65
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 64
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 64
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Yurong Lai, Xiaoyan Chu, Li Di, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2751-2777
Open Access | Times Cited: 56
Yurong Lai, Xiaoyan Chu, Li Di, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2751-2777
Open Access | Times Cited: 56
Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
Yuqing Liu, Xin Cheng, Hongli Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Yuqing Liu, Xin Cheng, Hongli Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Nebulization of extracellular vesicles: A promising small RNA delivery approach for lung diseases
Yohan Han, Yin Zhu, Hannah Youngblood, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 556-569
Open Access | Times Cited: 40
Yohan Han, Yin Zhu, Hannah Youngblood, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 556-569
Open Access | Times Cited: 40
A circular RNA activated by TGFβ promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability
Ke Li, Jiawei Guo, Yue Ming, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Ke Li, Jiawei Guo, Yue Ming, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
Recent progress in miRNA biogenesis and decay
Xavier Bofill-De Ros, Ulf Andersson Ørom
RNA Biology (2023) Vol. 21, Iss. 1, pp. 36-43
Open Access | Times Cited: 29
Xavier Bofill-De Ros, Ulf Andersson Ørom
RNA Biology (2023) Vol. 21, Iss. 1, pp. 36-43
Open Access | Times Cited: 29
Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology
Edward O. Olufunmilayo, R. M. Damian Holsinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12498-12498
Open Access | Times Cited: 28
Edward O. Olufunmilayo, R. M. Damian Holsinger
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12498-12498
Open Access | Times Cited: 28
mRNA delivery in cancer immunotherapy
Yichen Zhong, Shi Du, Yizhou Dong
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 4, pp. 1348-1357
Open Access | Times Cited: 26
Yichen Zhong, Shi Du, Yizhou Dong
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 4, pp. 1348-1357
Open Access | Times Cited: 26
RNAJP: enhanced RNA 3D structure predictions with non-canonical interactions and global topology sampling
Jun Li, Shi‐Jie Chen
Nucleic Acids Research (2023) Vol. 51, Iss. 7, pp. 3341-3356
Open Access | Times Cited: 24
Jun Li, Shi‐Jie Chen
Nucleic Acids Research (2023) Vol. 51, Iss. 7, pp. 3341-3356
Open Access | Times Cited: 24
The Growing Class of Novel RNAi Therapeutics
Gavin M. Traber, Ai‐Ming Yu
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 13-20
Open Access | Times Cited: 13
Gavin M. Traber, Ai‐Ming Yu
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 13-20
Open Access | Times Cited: 13
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 13
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 13
Reliable method for predicting the binding affinity of RNA-small molecule interactions using machine learning
Sowmya Ramaswamy Krishnan, Arijit Roy, M. Michael Gromiha
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 11
Sowmya Ramaswamy Krishnan, Arijit Roy, M. Michael Gromiha
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 11
RNATACs: Multispecific small molecules targeting RNA by induced proximity
Yan Song, Jia Cui, Jiaqiang Zhu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1101-1117
Open Access | Times Cited: 10
Yan Song, Jia Cui, Jiaqiang Zhu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1101-1117
Open Access | Times Cited: 10
Therapeutic potential of combating cancer by restoring wild-type p53 through mRNA nanodelivery
Divya Kamath, Tomoo Iwakuma, Stefan H. Bossmann
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 56, pp. 102732-102732
Open Access | Times Cited: 8
Divya Kamath, Tomoo Iwakuma, Stefan H. Bossmann
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 56, pp. 102732-102732
Open Access | Times Cited: 8
Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases
Luis Alberto Bravo-Vázquez, Sujay Paul, Miriam Guadalupe Colín-Jurado, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 8
Luis Alberto Bravo-Vázquez, Sujay Paul, Miriam Guadalupe Colín-Jurado, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 8